Patients with prostate cancer who did not respond to prostate‐specific membrane antigen‐targeted alpha‐radiation therapy had their BRCA1 and BRCA2 genes removed, and multiple BRCA1 variations had been found.271. This evidence concerns the gene BRCA1 and prostate carcinoma.